Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
about
Vaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adultsVaccines for post-exposure prophylaxis against varicella (chickenpox) in children and adults[The epidemiology of varicella disease in Germany after introduction of a vaccination recommendation : Analysis of mandatory and sentinel data between 2002 and 2014].Varicella vaccination in Europe - taking the practical approach.Primary versus secondary failure after varicella vaccination: implications for interval between 2 dosesImmune responses to mumps vaccine in adults who were vaccinated in childhood.Immunogenicity and safety of a tetravalent measles-mumps-rubella-varicella vaccine: an open-labeled, randomized trial in healthy Korean children.Economic evaluation of Varicella vaccination: results of a systematic review.Milestones along the road of infection prevention in Egypt.Complete DNA sequences of two oka strain varicella-zoster virus genomes.Cellular and humoral immunity after vaccination or natural mumps infection.
P2860
Q24193819-A6B8F6D0-7C05-4ED1-AD19-40350976C122Q24242809-E4E8BB75-B007-49F8-BCC9-3992E642E190Q31144265-995E858E-B6F8-41B4-9DC0-183510D75443Q33454919-00F56C14-F06E-47F1-B801-E227D07F5D94Q33880341-3409FD07-F1B5-4EC4-BDB9-1853FDBD6582Q36922479-12BF96FB-1B84-4E92-8D50-C3D5CD34243EQ37473550-BD39C24D-7CA8-4962-AE5C-BCB0C937D655Q37530362-01D2A4DB-1987-45A8-BBF6-BA530EA27006Q38558433-49522BC3-A363-40EF-B087-5FEB16946680Q43251025-0FD41F6B-93E0-4AC0-AF1C-D7F68ED91C58Q53803564-7C7482BA-C491-49E5-B23D-8071A1BA2D91
P2860
Immunogenicity and safety of a second dose of measles-mumps-rubella-varicella vaccine in healthy children aged 5 to 6 years.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年論文
@yue
2007年論文
@zh-hant
2007年論文
@zh-hk
2007年論文
@zh-mo
2007年論文
@zh-tw
2007年论文
@wuu
2007年论文
@zh
2007年论文
@zh-cn
name
Immunogenicity and safety of a ...... hy children aged 5 to 6 years.
@en
type
label
Immunogenicity and safety of a ...... hy children aged 5 to 6 years.
@en
prefLabel
Immunogenicity and safety of a ...... hy children aged 5 to 6 years.
@en
P2093
P1476
Immunogenicity and safety of a ...... hy children aged 5 to 6 years.
@en
P2093
Maija Baer
Paul Willems
Timo Vesikari
P304
P356
10.1097/01.INF.0000250689.09396.21
P577
2007-02-01T00:00:00Z